iDD biotech

iDD biotech  est membre de Lyonbiopôle

General information

Bâtiment Accinov / 317 avenue Jean-Jaures

69007 Lyon

Incorporated in: 2008/05/14

Number of employees: 17

Turnover: €2M (in 2015)


More information

 

Main activity

    iDD biotech is a biopharmaceutical company focused on developing innovative products in targeted immunotherapy, based upon monoclonal antibodies, for the treatment of cancer, autoimmune diseases and inflammation. The company is aiming at reinforcing the therapeutic arsenal and the pipeline of pharmaceutical companies.


Funding

Looking for funding: Yes

Nature of funding searches: We are looking for the second financial round from Capital development.

Private funding obtained: In progress

Public funding obtained: Financial FUI support: PRAVIC (537 k€), GLIADYS (1 474 k€), ACILIMAB (592 k€), CLARA IPROMAH (250 k€), CLARA THERA8 (300 k€)      

Stock exchange listing: Not applicable

Segmentation
Activities
Products / Services / Technologies
Partnership opportunities / Licensing

Strategic area of application
Human Medicine


Application market
Immune, AutoIm & Inflam. diseases - Neurological diseases - Oncology


Activities
Therapeutics, Pharma or Biotech


Technologies
Nanotechnology - Antibodies - Protein - Peptide

En poursuivant votre navigation sur ce site, vous acceptez l'utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d'intérêt. En savoir plus... Fermer